KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	BRAZIKUMAB (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97 💬
2	Brazikumab high dose (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
3	Brazikumab Induction Dose (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97 💬
4	Brazikumab IV Infusion (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
5	Brazikumab low dose (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
6	Brazikumab Maintenance Dose (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97 💬
7	Brazikumab SC Injection (D10912)	[1] Brazikumab	[1] Brazikumab (D10912) 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬